State-of-the-art standard compliance manufacturing facility (ISO/cGMP). Initial Focus Cannabis-derived high-quality APIs and Reference Standards. Manufacturing and supplying of various active pharmaceutical ingredients (API) for pre-clinical, clinical & commercial use. We focus on rare or not yet existing APIs, e.g. cannabis-derived isolates and designer oils. Other proprietary therapeutically active product families in pipeline. Isorama refines existing oils that failed regulatory stipulated testing requirements. A novel high efficiency separation process creates specific cannabinoid isolates and terpene fractions, that are characterized with future-proof state-of-the-art analytical methods.